Alcami sells Dutch API facility to MercachemSyncom
Alcami downsizes in Europe through the sale of its API facility to MercachemSyncom, as it expands its presence in North America.
Alcami downsizes in Europe through the sale of its API facility to MercachemSyncom, as it expands its presence in North America.
Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.
The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.